News
-
Torq Announces Debt Settlement and Corporate Update
-
Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
-
Groete Access Road Nears Completion
-
MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
-
All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
-
PUMA CCO Matthias Baeumer to step down from Management Board
-
Cairn Homes Plc: Transaction in Own Shares
-
NAGRAVISION and MediaTek Broaden Partnership to Redefine Content Security for Premium Content on Connected TVs
-
Club Offers for Travel Enthusiasts in Germany
-
Club Offers for Travel Enthusiasts in Germany
-
Transparantiekennisgeving van Baltisse Groep
-
Transparency notification by Baltisse Group
-
BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
-
BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
-
Availability of the 2026 Interim Financial Report